Cardioprotective Agents for the Primary Prevention of Trastuzumab-Associated Cardiotoxicity: A Systematic Review and Meta-Analysis

There are significant considerations about the prevention of cardiotoxicity caused by trastuzumab therapy in patients with breast cancer, leading to discontinuation. Recently, randomized controlled trials (RCTs) have evaluated the effects of early commitment of beta-blockers (BBs), angiotensin recep...

Descripción completa

Detalles Bibliográficos
Autores principales: Goulas, Kyriakos, Farmakis, Dimitrios, Constantinidou, Anastasia, Kadoglou, Nikolaos P. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383255/
https://www.ncbi.nlm.nih.gov/pubmed/37513895
http://dx.doi.org/10.3390/ph16070983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383255/
https://www.ncbi.nlm.nih.gov/pubmed/37513895
http://dx.doi.org/10.3390/ph16070983

Ejemplares similares